Sie befinden Sich nicht im Netzwerk der Universität Paderborn. Der Zugriff auf elektronische Ressourcen ist gegebenenfalls nur via VPN oder Shibboleth (DFN-AAI) möglich. mehr Informationen...
Sortiert nach
    Datensatz exportieren als...
  • BibTeX
Phase II trial of oral piritrexim in advanced, previously treated transitional cell cancer of bladder
Investigational new drugs, 1997-01, Vol.15 (2), p.157-163
1997
Volltextzugriff (PDF)
    Datensatz exportieren als...
  • BibTeX
Phase I trial of the thymidylate synthase inhibitor AG331 as a 5-day continuous infusion
Clinical cancer research, 1996-10, Vol.2 (10), p.1685-1692
1996
Volltextzugriff (PDF)
    Datensatz exportieren als...
  • BibTeX
Phase II trial of piritrexim in metastatic melanoma using intermittent, low-dose administration
Journal of clinical oncology, 1991-03, Vol.9 (3), p.464-467
1991
Volltextzugriff (PDF)
    Datensatz exportieren als...
  • BibTeX
Phase I study of AG2034, a targeted GARFT inhibitor, administered once every 3 weeks
Cancer chemotherapy and pharmacology, 2000, Vol.45 (5), p.423-427
2000
Volltextzugriff (PDF)
    Datensatz exportieren als...
  • BibTeX
Phase II trial of piritrexim and DTIC using an alternating dose schedule in metastatic melanoma
American journal of clinical oncology, 1995-12, Vol.18 (6), p.488-490
1995
Volltextzugriff (PDF)
Open Access
    Datensatz exportieren als...
  • BibTeX
Neoadjuvant PFL augmented by methotrexate and piritrexim followed by concomitant chemoradiotherapy for advanced head and neck cancer: A feasible and active approach
Annals of oncology, 1992-01, Vol.3 (1), p.79-81
1992
Volltextzugriff (PDF)
    Datensatz exportieren als...
  • BibTeX
A phase II study of vinblastine in combination with acrivastine in patients with advanced renal cell carcinoma
Investigational new drugs, 1994-01, Vol.12 (2), p.137-141
1994
Volltextzugriff (PDF)
    Datensatz exportieren als...
  • BibTeX
Phase I Trial of Piritrexim Capsules Using Prolonged, Low-Dose Oral Administration for the Treatment of Advanced Malignancies
JNCI : Journal of the National Cancer Institute, 1991-01, Vol.83 (1), p.51-55
1991
Volltextzugriff (PDF)
    Datensatz exportieren als...
  • BibTeX
Oral piritrexim : a phase II study in patients with advanced soft tissue sarcoma
Investigational new drugs, 1992-07, Vol.10 (2), p.97-98
1992
Volltextzugriff (PDF)
Open Access
    Datensatz exportieren als...
  • BibTeX
A phase II study of piritrexim in patients with advanced squamous head and neck cancer
Cancer, 1992-02, Vol.69 (4), p.1008-1011
1992
Volltextzugriff (PDF)
    Datensatz exportieren als...
  • BibTeX
Phase I clinical and pharmacology study of 502U83 given as a 24-h continuous intravenous infusion
Cancer chemotherapy and pharmacology, 1993-01, Vol.31 (4), p.283-288
1993
Volltextzugriff (PDF)
    Datensatz exportieren als...
  • BibTeX
Initial clinical trial and pharmacokinetics of Thymitaq (AG337) by 10-day continuous infusion in patients with advanced solid tumors
Cancer chemotherapy and pharmacology, 1998, Vol.41 (2), p.167
1998
Volltextzugriff (PDF)
Open Access
    Datensatz exportieren als...
  • BibTeX
A phase II study of piritrexim in combination with methotrexate in recurrent and metastatic head and neck cancer
Cancer, 1991-05, Vol.67 (9), p.2253-2257
1991
Volltextzugriff (PDF)
    Datensatz exportieren als...
  • BibTeX
A phase I clinical and pharmacological study of weekly intravenous infusions of piritrexim (BW301U)
European journal of cancer & clinical oncology, 1989-12, Vol.25 (12), p.1867-1873
1989
Volltextzugriff (PDF)
    Datensatz exportieren als...
  • BibTeX
Phase I evaluation of 773U82-HCl in a two-hour infusion repeated daily for three days
Investigational new drugs, 1992-11, Vol.10 (4), p.279-287
1992
Volltextzugriff (PDF)
    Datensatz exportieren als...
  • BibTeX
A pilot study of piritrexim in mycosis fungoides
Archives of dermatology (1960), 1992-04, Vol.128 (4), p.561
1992
Volltextzugriff (PDF)
Open Access
    Datensatz exportieren als...
  • BibTeX
Multicenter Phase I Trial of the Mitogen-Activated Protein Kinase 1/2 Inhibitor BAY 86-9766 in Patients with Advanced Cancer
Clinical cancer research, 2013-03, Vol.19 (5), p.1232-1243
2013
Volltextzugriff (PDF)
Open Access
    Datensatz exportieren als...
  • BibTeX
A Phase I Study of the Safety, Pharmacokinetics, and Pharmacodynamics of Combination Therapy with Refametinib plus Sorafenib in Patients with Advanced Cancer
Clinical cancer research, 2016-05, Vol.22 (10), p.2368-2376
2016
Volltextzugriff (PDF)
Open Access
    Datensatz exportieren als...
  • BibTeX
Phase I and Pharmacokinetic Study of Prinomastat, a Matrix Metalloprotease Inhibitor
Clinical cancer research, 2004-02, Vol.10 (3), p.909-915
2004
Volltextzugriff (PDF)
Open Access
    Datensatz exportieren als...
  • BibTeX
Result of two randomized trials comparing nolatrexed (Thymitaq™) versus methotrexate in patients with recurrent head and neck cancer
Annals of oncology, 2001-11, Vol.12 (11), p.1595-1599
2001
Volltextzugriff (PDF)
    Datensatz exportieren als...
  • BibTeX
Phase I Studies with the Nonclassical Antifolate Nolatrexed Dihydrochloride (AG337, THYMITAQ) Administered Orally for 5 Days
Clinical cancer research, 1999-01, Vol.5 (1), p.111-118
1999
Volltextzugriff (PDF)
    Datensatz exportieren als...
  • BibTeX
Preclinical and phase I clinical studies with the nonclassical antifolate thymidylate synthase inhibitor nolatrexed dihydrochloride given by prolonged administration in patients with solid tumors
Journal of clinical oncology, 1998-03, Vol.16 (3), p.1131-1141
1998
Volltextzugriff (PDF)
1 – 22 von 22
Suche als RSS-Feed
Aktive Filter
ThemaAged
Suchergebnisse filtern
Filter anzeigen